FdaApplication
ANDA 205229
Identifiers
- fda_app_no: ANDA205229
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2017-10-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROGESTERONE | PROGESTERONE | 100MG | CAPSULE;ORAL |
| PROGESTERONE | PROGESTERONE | 200MG | CAPSULE;ORAL |
2 products